Zuyderland MC
Welcome,         Profile    Billing    Logout  
 9 Trials 
11 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Piessen, Guillaume
NEONIPIGA, NCT04006262: Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma.

Checkmark Data from NEONIPIGA trial of nivolumab/ipilimumab neoadjuvant therapy in dMMR/MSI-H gastric or gastroesophageal junction adenocarcinoma
Aug 2022 - Aug 2022: Data from NEONIPIGA trial of nivolumab/ipilimumab neoadjuvant therapy in dMMR/MSI-H gastric or gastroesophageal junction adenocarcinoma
Recruiting
2
32
Europe
Nivolumab 10 MG/ML, Opdivo, Ipilimumab 200 MG in 40 ML Injection, Yervoy
GERCOR - Multidisciplinary Oncology Cooperative Group, Bristol-Myers Squibb
Localized Oesogastric Adenocarcimona, MSI and or dMMR
06/24
06/24
Endeavor-1, NCT06523374: A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer

Not yet recruiting
N/A
50
Europe
Endoscopic brush cytology
University Hospital, Antwerp, Karolinska Institutet, Universal Diagnostics, Amsterdam UMC, Radboud University Medical Center, AZ Delta, Centre Hospitalier Universitaire de Liege, University of Leipzig, IRCCS Ospedale San Raffaele, Karolinska University Hospital, University of Dublin, Trinity College, Heinrich-Heine University, Duesseldorf, GZA Ziekenhuizen Campus Sint-Augustinus, University Hospital, Ghent, Rigshospitalet, Denmark, Universitätsklinikum Leipzig, St. James's Hospital, Ireland
Barrett's Esophagus, Esophageal Adenocarcinoma
11/25
11/26
Hof, Arnoud WJ van 't
CELEBRATE, NCT04825743 / 2020-003320-16: A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

Recruiting
3
2499
Europe, Canada, RoW
zalunfiban, RUC-4, Placebo
CeleCor Therapeutics, CeleCor Therapeutics, Inc.
ST-elevation Myocardial Infarction (STEMI)
12/24
12/24
Rasoul, Saman
NCT06383390: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

Recruiting
3
10000
Europe, Canada, US, RoW
Retatrutide, LY3437943, Placebo
Eli Lilly and Company
Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD)
02/29
02/29
NCT05198674: SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Recruiting
N/A
1400
Europe, US, RoW
Renal Denervation (Symplicity Spyral™), Renal Angiography, Renal Denervation
Medtronic Vascular
Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus
11/26
11/29
Rasoul, S
CELEBRATE, NCT04825743 / 2020-003320-16: A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

Recruiting
3
2499
Europe, Canada, RoW
zalunfiban, RUC-4, Placebo
CeleCor Therapeutics, CeleCor Therapeutics, Inc.
ST-elevation Myocardial Infarction (STEMI)
12/24
12/24
Vainer, J
CELEBRATE, NCT04825743 / 2020-003320-16: A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

Recruiting
3
2499
Europe, Canada, RoW
zalunfiban, RUC-4, Placebo
CeleCor Therapeutics, CeleCor Therapeutics, Inc.
ST-elevation Myocardial Infarction (STEMI)
12/24
12/24
Luijkx, Jasper
RE-DUAL PCI, NCT04688723: Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI

Recruiting
4
1000
Europe
Dabigatran + Ticagrelor, Dabigatran + clopidogrel
Zuyderland Medisch Centrum, Boehringer Ingelheim
Coronary Artery Disease, Myocardial Ischemia, Myocardial Infarction, Atrial Fibrillation
12/22
07/23
Winkler, Patty
RE-DUAL PCI, NCT04688723: Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI

Recruiting
4
1000
Europe
Dabigatran + Ticagrelor, Dabigatran + clopidogrel
Zuyderland Medisch Centrum, Boehringer Ingelheim
Coronary Artery Disease, Myocardial Ischemia, Myocardial Infarction, Atrial Fibrillation
12/22
07/23
Hoef, T P van de
CELEBRATE, NCT04825743 / 2020-003320-16: A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

Recruiting
3
2499
Europe, Canada, RoW
zalunfiban, RUC-4, Placebo
CeleCor Therapeutics, CeleCor Therapeutics, Inc.
ST-elevation Myocardial Infarction (STEMI)
12/24
12/24
Belgers, Eric
A1Check, NCT05810207: the External Validation of a Machine Learning Model Predicting Colorectal Anastomotic Leakage

Recruiting
N/A
1000
Europe
Colorectal resection
Freek Daams, SAS Institute
Anastomotic Leak, Anastomotic Leak Large Intestine, Anastomotic Complication, Anastomotic Leak Rectum
07/24
12/24
Claassen, Lieke
No trials found

Download Options